CVS Health Corporation CVS NYSE

CVS Health Corporation (CVS) generated $10.64B in operating cash flow for fiscal year 2025. After capital expenditures of $2.83B, free cash flow was $7.81B.

Free cash flow margin was 1.9% of revenue. Cash conversion ratio was 6.02x, indicating earnings are backed by cash.

The company returned $3.4B in dividends to shareholders during the period.

Criteria supported by this page:

• HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (51/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (30/100) — Cash conversion ratio was 6.02x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 55/100 with 2/7 criteria passed.